Strengthening Families & Communities LLC’s Takeda Pharmaceutical TAK Stock Holding History

Strengthening Families & Communities LLC’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.1K	Hold	814	–	–	﹤0.01%	342
2026 Q1	$15.1K	Buy	+814	New	+$14.3K	﹤0.01%	308
2025 Q4	–	Sell	-798	Closed	-$11.7K	–	709
2025 Q3	$11.7K	Buy	+798	New	+$11.9K	﹤0.01%	367
2024 Q4	–	Sell	-768	Closed	-$10.9K	–	541
2024 Q3	$10.9K	Buy	768 +15	+2%	+$213	﹤0.01%	349
2024 Q2	$10K	Buy	+753	New	+$9.97K	﹤0.01%	381
2023 Q4	–	Sell	-753	Closed	-$12K	–	379
2023 Q3	$12K	Hold	753	–	–	0.01%	300
2023 Q2	$12K	Buy	+753	New	+$12.3K	0.01%	325
2022 Q4	$12K	Hold	782	–	–	0.01%	225
2022 Q3	$10K	Hold	782	–	–	0.01%	339
2022 Q2	$11K	Hold	782	–	–	0.01%	219
2022 Q1	$11K	Hold	782	–	–	0.01%	218
2021 Q4	$612K	Buy	+782	New	+$11K	0.14%	80

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Strengthening Families & Communities LLC's TAK Position: Q2 2026 in Review

Strengthening Families & Communities LLC held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 814 shares worth $13.1K. The position accounts for ﹤0.01% of the portfolio, ranked #342.

Strengthening Families & Communities LLC first reported a position in TAK in Q4 2021 and has held it in 12 quarters since. The position peaked at $612K in Q4 2021. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Strengthening Families & Communities LLC held 814 shares of Takeda Pharmaceutical worth $13.1K as of Q2 2026.
Strengthening Families & Communities LLC left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #342 holding.
Strengthening Families & Communities LLC first reported a position in Takeda Pharmaceutical in Q4 2021 and has held it in 12 quarters since.
Strengthening Families & Communities LLC's Takeda Pharmaceutical position peaked at $612K in Q4 2021.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.